Search

Your search keyword '"Davide Pastorelli"' showing total 6 results
Start Over Author "Davide Pastorelli" Journal annals of oncology
6 results on '"Davide Pastorelli"'

1. CAPTEM or FOLFIRI as second-line therapy in neuroendocrine carcinomas and exploratory analysis of predictive role of PET imaging and biological markers (SENECA study)

Author

Davide Pastorelli, M. Cives, Daniele Santini, Toni Ibrahim, Francesca Bergamo, G. Di Meglio, Francesca Pucci, Sergio Ricci, Sara Pusceddu, Angela Buonadonna, Davide Campana, Silvana Leo, Rossana Berardi, Fabio Gelsomino, Ivan Lolli, N. Silvestris, A. Russo, Alberto Bongiovanni, Flavia Foca, and Stefano Tamberi

Subjects
Oncology, Second-line therapy, medicine.medical_specialty, business.industry, Internal medicine, FOLFIRI, medicine, Hematology, Exploratory analysis, Pet imaging, business, Neuroendocrine Carcinomas
Published
2018
Full Text
View/download PDF

2. A phase II study of Gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature

Author

Giuseppe Cartei, S. Cingarlini, F. Salmaso, G. Artioli, Fable Zustovich, Stefania Zovato, M. Dal Bianco, Davide Pastorelli, Renato Ceravolo, Samuela Binato, and L. De Zorzi

Subjects
Adult, Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Alpha interferon, Phases of clinical research, Deoxycytidine, chemistry.chemical_compound, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Combined Modality Therapy, Carcinoma, Renal Cell, Aged, business.industry, Interferon-alpha, Cancer, Hematology, Immunotherapy, Middle Aged, medicine.disease, Gemcitabine, Kidney Neoplasms, chemistry, Interleukin-2, Female, Topotecan, business, medicine.drug
Published
2006
Full Text
View/download PDF

4. Phase II study of Gemcitabine and Curcumin (Meriva®) as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary results

Author

Davide Pastorelli, Romeo Bardini, Fulvio Ursini, Massimo Gion, Camillo Aliberti, Cosimo Sperti, Pasquale Fiduccia, Caterina Soldà, and G. Da Dalt

Subjects
Oncology, medicine.medical_specialty, business.industry, Locally advanced, Phases of clinical research, Hematology, Gemcitabine, First line treatment, chemistry.chemical_compound, chemistry, Internal medicine, Metastatic pancreatic cancer, medicine, Curcumin, business, medicine.drug
Published
2015
Full Text
View/download PDF

5. O-005 Ramucirumab (RAM) as second-Line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib: comprehensive results from the randomized phase III REACH study

Author

Peter Malfertheiner, Joerg Trojan, Javier Sastre, Baek-Yeol Ryoo, Andrew X. Zhu, C.-J. Yen, Markus Peck-Radosavljevic, J.O. Park, Ronnie Tp Poon, L. Yang, Davide Pastorelli, Paolo Abada, Ian Chau, Allicia C. Girvan, Takuji Okusaka, Katerina Kubackova, Shao Chun Chang, A. Baron, H.C. Chung, Masatoshi Kudo, J.-F. Blanc, and T. Flesch Pfiffer

Subjects
Oncology, Sorafenib, medicine.medical_specialty, Second line treatment, business.industry, Hematology, medicine.disease, Ramucirumab, First line therapy, Hepatocellular carcinoma, Internal medicine, medicine, In patient, business, medicine.drug
Published
2015
Full Text
View/download PDF

6. P-036 Phase II study of gemcitabine and curcumin as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary data

Author

G. Da Dalt, Pasquale Fiduccia, Massimo Gion, Romeo Bardini, Caterina Soldà, Fulvio Ursini, Camillo Aliberti, Cosimo Sperti, and Davide Pastorelli

Subjects
Oncology, medicine.medical_specialty, business.industry, Locally advanced, Phases of clinical research, Hematology, Gemcitabine, First line treatment, chemistry.chemical_compound, chemistry, Pancreatic Cancer Stage IV, Internal medicine, Metastatic pancreatic cancer, Curcumin, Medicine, business, medicine.drug
Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results